Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v4-FR
Language English French
Date Updated 2020-06-27 2020-06-26
Drug Identification Number 02239834 02239834
Brand name LUPRON DEPOT LUPRON DEPOT
Common or Proper name Lupron depot 11.25mg Lupron depot 11.25mg
Company Name ABBVIE CORPORATION ABBVIE CORPORATION
Ingredients LEUPROLIDE ACETATE LEUPROLIDE ACETATE
Strength(s) 11.25MG 11.25MG
Dosage form(s) POWDER FOR SUSPENSION, SUSTAINED-RELEASE POWDER FOR SUSPENSION, SUSTAINED-RELEASE
Route of administration INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 syringe (11.25mg) 1 syringe (11.25mg)
ATC code L02AE L02AE
ATC description HORMONES AND RELATED AGENTS HORMONES AND RELATED AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2020-06-26 2020-06-26
Actual start date
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments We are currently monitoring our inventory of Lupron 11,25mg (3 month) due to a manufacturing delay. AbbVie is acting quickly to minimize any potential impact from this situation, by managing existing inventory. During that period, orders will be processed to supply minimal quantity required to meet patient needs. Please contact our Customer Services Department for Lupron 3,75mg (1 month) or Orilissa 200mg BID as possible alternatives at 1-888-704-8270. We are currently monitoring our inventory of Lupron 11,25mg (3 month) due to a manufacturing delay. AbbVie is acting quickly to minimize any potential impact from this situation, by managing existing inventory. During that period, orders will be processed to supply minimal quantity required to meet patient needs. Please contact our Customer Services Department for Lupron 3,75mg (1 month) or Orilissa 200mg BID as possible alternatives at 1-888-704-8270.
Health Canada comments